MicroRNA-26a induced by hypoxia targets HDAC6 in myogenic differentiation of embryonic stem cells

Nucleic Acids Research

Volumn 43, Issue 4, 2015, Pages 2057-2073

  Lee, Sae Won ^a   Yang, Jimin ^a   Kim, Su Yeon ^a   Jeong, Han Kyul ^a   Lee, Jaewon ^a   Kim, Woo Jean ^b   Lee, Eun Ju ^a   Kim, Hyo Soo ^a,c  

^a Seoul National University Hospital   (South Korea)

^b Inha University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HDAC6 PROTEIN, MOUSE; HISTONE DEACETYLASE; MICRORNA; MIRN26 MICRORNA, MOUSE; TRANSCRIPTION FACTOR PAX7;

ANIMAL; C57BL MOUSE; CELL CULTURE; CELL HYPOXIA; CELL LINEAGE; CYTOLOGY; DOWN REGULATION; EMBRYONIC STEM CELL; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; MALE; MESODERM; METABOLISM; MUSCLE DEVELOPMENT; PHYSIOLOGY; PROMOTER REGION; REGENERATION; SKELETAL MUSCLE;

ANIMALS; CELL HYPOXIA; CELL LINEAGE; CELLS, CULTURED; DOWN-REGULATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; HISTONE DEACETYLASES; MALE; MESODERM; MICE, INBRED C57BL; MICRORNAS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; PAX7 TRANSCRIPTION FACTOR; PROMOTER REGIONS, GENETIC; REGENERATION;

EID: 84941959292     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv088     Document Type: Article

References (48)

1. Lee, S.W., Kim, W.J., Choi, Y.K., Song, H.S., Son, M.J., Gelman, I.H., Kim, Y.J., Kim, K.W. (2003) SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat. Med., 9, 900-906.
2. Semenza, G.L. (2014) Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu. Rev. Pathol., 9, 47-71.
3. Lee, S.W., Lee, Y.M., Bae, S.K., Murakami, S., Yun, Y., Kim, K.W. (2000) Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem. Biophys. Res. Commun., 268, 456-461.
4. Kim, M.S., Kwon, H.J., Lee, Y.M., Baek, J.H., Jang, J.E., Lee, S.W., Moon, E.J., Kim, H.S., Lee, S.K., Chung, H.Y. et al. (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med., 7, 437-443.
5. Youn, S.W., Lee, S.W., Lee, J., Jeong, H.K., Suh, J.W., Yoon, C.H., Kang, H.J., Kim, H.Z., Koh, G.Y., Oh, B.H. et al. (2011) COMP-Ang1 stimulates HIF-1alpha-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. Blood, 117, 4376-4386.
6. Lee, S.W., Jeong, H.K., Lee, J.Y., Yang, J., Lee, E.J., Kim, S.Y., Youn, S.W., Lee, J., Kim, W.J., Kim, K.W. et al. (2012) Hypoxic priming of mESCs accelerates vascular-lineage differentiation through HIF1-mediated inverse regulation of Oct4 and VEGF. EMBO Mol. Med., 4, 924-938.
7. de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S., van Kuilenburg, A.B. (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J., 370, 737-749.
8. Hodawadekar, S.C., Marmorstein, R. (2007) Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design. Oncogene, 26, 5528-5540.
9. Aldana-Masangkay, G.I., Sakamoto, K.M. (2011) The role of HDAC6 in cancer. J. Biomed. Biotechnol., 2011, 875824.
10. Kaluza, D., Kroll, J., Gesierich, S., Yao, T.P., Boon, R.A., Hergenreider, E., Tjwa, M., Rossig, L., Seto, E., Augustin, H.G. et al. (2011) Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin. EMBO J., 30, 4142-4156.
11. Kawaguchi, Y., Kovacs, J.J., McLaurin, A., Vance, J.M., Ito, A., Yao, T.P. (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell, 115, 727-738.
12. Birdsey, G.M., Dryden, N.H., Shah, A.V., Hannah, R., Hall, M.D., Haskard, D.O., Parsons, M., Mason, J.C., Zvelebil, M., Gottgens, B. et al. (2012) The transcription factor Erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis. Blood, 119, 894-903.
13. Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H., Benvenisty, N. (2000) Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med., 6, 88-95.
14. Li, X., Li, L., Pandey, R., Byun, J.S., Gardner, K., Qin, Z., Dou, Y. (2012) The histone acetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptional network. Cell Stem Cell, 11, 163-178.
15. Tan, Y., Xue, Y., Song, C., Grunstein, M. (2013) Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. U.S.A., 110, 11 493-11 498.
16. Durcova-Hills, G., Tang, F., Doody, G., Tooze, R., Surani, M.A. (2008) Reprogramming primordial germ cells into pluripotent stem cells. PLoS One, 3, e3531.
17. Hai, T., Hao, J., Wang, L., Jouneau, A., Zhou, Q. (2011) Pluripotency maintenance in mouse somatic cell nuclear transfer embryos and its improvement by treatment with the histone deacetylase inhibitor TSA. Cell. Reprogramm., 13, 47-56.
18. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., Melton, D.A. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 26, 1269-1275.
19. Moschidou, D., Mukherjee, S., Blundell, M.P., Drews, K., Jones, G.N., Abdulrazzak, H., Nowakowska, B., Phoolchund, A., Lay, K., Ramasamy, T.S. et al. (2012) Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol. Ther., 20, 1953-1967.
20. Kretsovali, A., Hadjimichael, C., Charmpilas, N. (2012) Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming. Stem Cells Int., 2012, 184154.
21. Paino, F., La Noce, M., Tirino, V., Naddeo, P., Desiderio, V., Pirozzi, G., De Rosa, A., Laino, L., Altucci, L., Papaccio, G. (2014) Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement. Stem Cells, 32, 279-289.
22. Dong, X., Pan, R., Zhang, H., Yang, C., Shao, J., Xiang, L. (2013) Modification of histone acetylation facilitates hepatic differentiation of human bone marrow mesenchymal stem cells. PLoS One, 8, e63405.
23. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
24. Lee, H.J. (2013) Exceptional stories of microRNAs. Exp. Biol. Med. (Maywood), 238, 339-343.
25. Kozomara, A., Griffiths-Jones, S. (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res., 39, D152-D157.
26. Kloosterman, W.P., Plasterk, R.H. (2006) The diverse functions of microRNAs in animal development and disease. Dev. Cell, 11, 441-450.
27. McCarthy, J.J. (2011) The MyomiR network in skeletal muscle plasticity. Exerc. Sport Sci. Rev., 39, 150-154.
28. Heinrich, E.M., Dimmeler, S. (2012) MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. Circ. Res., 110, 1014-1022.
29. Mizuno, Y., Chang, H., Umeda, K., Niwa, A., Iwasa, T., Awaya, T., Fukada, S., Yamamoto, H., Yamanaka, S., Nakahata, T. et al. (2010) Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J., 24, 2245-2253.
30. Darabi, R., Gehlbach, K., Bachoo, R.M., Kamath, S., Osawa, M., Kamm, K.E., Kyba, M., Perlingeiro, R.C. (2008) Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med., 14, 134-143.
31. Patel, J.B., Appaiah, H.N., Burnett, R.M., Bhat-Nakshatri, P., Wang, G., Mehta, R., Badve, S., Thomson, M.J., Hammond, S., Steeg, P. et al. (2011) Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene, 30, 1290-1301.
32. Mohamed, J.S., Lopez, M.A., Boriek, A.M. (2010) Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J. Biol. Chem., 285, 29336-29347.
33. Frank, S.R., Schroeder, M., Fernandez, P., Taubert, S., Amati, B. (2001) Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev., 15, 2069-2082.
34. Yeo, E.J., Chun, Y.S., Cho, Y.S., Kim, J., Lee, J.C., Kim, M.S., Park, J.W. (2003) YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl. Cancer Inst., 95, 516-525.
35. Liu, N., Williams, A.H., Maxeiner, J.M., Bezprozvannaya, S., Shelton, J.M., Richardson, J.A., Bassel-Duby, R., Olson, E.N. (2012) microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest., 122, 2054-2065.
36. Hoshino, S., Sakamoto, K., Vassilopoulos, S., Camus, S.M., Griffin, C.A., Esk, C., Torres, J.A., Ohkoshi, N., Ishii, A., Tamaoka, A. et al. (2013) The CHC22 clathrin-GLUT4 transport pathway contributes to skeletal muscle regeneration. PLoS One, 8, e77787.
37. Winter, M., Moser, M.A., Meunier, D., Fischer, C., Machat, G., Mattes, K., Lichtenberger, B.M., Brunmeir, R., Weissmann, S., Murko, C. et al. (2013) Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis. EMBO J., 32, 3176-3191.
38. Seale, P., Sabourin, L.A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., Rudnicki, M.A. (2000) Pax7 is required for the specification of myogenic satellite cells. Cell, 102, 777-786.
39. Zammit, P.S., Relaix, F., Nagata, Y., Ruiz, A.P., Collins, C.A., Partridge, T.A., Beauchamp, J.R. (2006) Pax7 and myogenic progression in skeletal muscle satellite cells. J. Cell Sci., 119, 1824-1832.
40. Garcia-Ramirez, M., Rocchini, C., Ausio, J. (1995) Modulation of chromatin folding by histone acetylation. J. Biol. Chem., 270, 17923-17928.
41. Sengupta, N., Seto, E. (2004) Regulation of histone deacetylase activities. J. Cell. Biochem., 93, 57-67.
42. Patton, B.L., Connoll, A.M., Martin, P.T., Cunningham, J.M., Mehta, S., Pestronk, A., Miner, J.H., Sanes, J.R. (1999) Distribution of ten laminin chains in dystrophic and regenerating muscles. Neuromusc. Disord. : NMD, 9, 423-433.
43. Haberland, M., Montgomery, R.L., Olson, E.N. (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet., 10, 32-42.
44. Dinarello, C.A., Fossati, G., Mascagni, P. (2011) Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer. Mol. Med., 17, 333-352.
45. Loscalzo, J. (2010) The cellular response to hypoxia: tuning the system with microRNAs. J. Clin. Invest., 120, 3815-3817.
46. Wong, C.F., Tellam, R.L. (2008) MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J. Biol. Chem., 283, 9836-9843.
47. Dey, B.K., Gagan, J., Yan, Z., Dutta, A. (2012) miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev., 26, 2180-2191.
48. Tedesco, F.S., Dellavalle, A., Diaz-Manera, J., Messina, G., Cossu, G. (2010) Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J. Clin. Invest., 120, 11-19.